Colin D. Phipps

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma.

High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma.

Journal: Blood cancer journal

Published: June 29, 2021

Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Journal: Leukemia

Published: March 09, 2021

No association between ECSIT germline mutations and hemophagocytic lymphohistiocytosis in natural killer/T-cell lymphoma.

No association between ECSIT germline mutations and hemophagocytic lymphohistiocytosis in natural killer/T-cell lymphoma.

Journal: Haematologica

Published: August 12, 2020

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Journal: Leukemia

Published: May 21, 2020

Pralatrexate Induces Long-Term Remission in Relapsed Subcutaneous Panniculitis-Like T-Cell Lymphoma.

Pralatrexate Induces Long-Term Remission in Relapsed Subcutaneous Panniculitis-Like T-Cell Lymphoma.

Journal: Annals of the Academy of Medicine, Singapore

Published: November 19, 2019

Cell-of-origin and bone marrow involvement increase specificity of defining patients with diffuse large B-cell lymphoma at high risk of CNS relapse: a study of 793 patients treated with chemoimmunotherapy in Asia.

Cell-of-origin and bone marrow involvement increase specificity of defining patients with diffuse large B-cell lymphoma at high risk of CNS relapse: a study of 793 patients treated with chemoimmunotherapy in Asia.

Journal: Leukemia & lymphoma

Published: August 06, 2019

The impact of time from diagnosis to treatment in diffuse large B-cell lymphoma.

The impact of time from diagnosis to treatment in diffuse large B-cell lymphoma.

Journal: Leukemia & lymphoma

Published: January 19, 2018

Outcomes of patients with peripheral T-cell lymphoma in first complete remission: data from three tertiary Asian cancer centers.

Outcomes of patients with peripheral T-cell lymphoma in first complete remission: data from three tertiary Asian cancer centers.

Journal: Blood cancer journal

Published: September 11, 2017

Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis.

Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis.

Journal: British journal of haematology

Published: August 04, 2017

Durable remission is achievable with localized treatment and reduction of immunosuppression in limited stage EBV-related plasmablastic lymphoma.

Durable remission is achievable with localized treatment and reduction of immunosuppression in limited stage EBV-related plasmablastic lymphoma.

Journal: Annals of hematology

Published: July 10, 2017

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase.

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase.

Journal: Blood

Published: December 12, 2016

Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients.

Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients.

Journal: Oncotarget

Published: November 14, 2016

Showing 1-12 of 29

Last Updated: 09/26/2026